Wei Wen

3.8k citations

76 papers · 2.0k indexed · h-index 27

Co-authors: Thanh H. Dellinger Marsha A. Moses Dmitri Wiederschain Jack L. Arbiser Ernest Han Chee‐Onn Leong John H. Yim Richard Jove
Topics: Cancer Genomics and Diagnostics (9 papers)Cancer Mechanisms and Therapy (8 papers)Cytokine Signaling Pathways and Interactions (7 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nucleic Acids Research Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States China United Kingdom

In The Last Decade

Wei Wen

74 papers receiving 2.0k citations

Peers

Countries citing papers authored by Wei Wen

Since Specialization

Citations

This map shows the geographic impact of Wei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wen more than expected).

Fields of papers citing papers by Wei Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wen. The network helps show where Wei Wen may publish in the future.

Co-authorship network of co-authors of Wei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wen. A scholar is included among the top collaborators of Wei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wen. Wei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MARVEL: an integrated alternative splicing analysis platform for single-cell RNA sequencing data 2023 ·Nucleic Acids Research ·Wei Wen,Adam J. Mead,Supat Thongjuea	13
2	Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer 2022 ·BMC Gastroenterology ·Bing Yan,(unknown),Qianwen Ye,(unknown),(unknown),Mingyue Xu,(unknown),Wei Wen	4
3	Residue Specific Binding Mechanisms of PD-1 to Its Monoclonal Antibodies by Computational Alanine Scanning 2021 ·Gaodeng xuexiao huaxue xuebao ·Wei Wen,(unknown),(unknown),John Z. H. Zhang	1
4	Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development 2021 ·Cell Reports ·Anindita Roy,Guanlin Wang,Deena Iskander,Sorcha O’Byrne,Natalina Elliott,Jennifer O’Sullivan,Gemma Buck,Elisabeth F. Heuston,Wei Wen,Alba Rodríguez-Meira,Hua Peng,Anastasios Karadimitris,Adam J. Mead,David M. Bodine,Irene Roberts,Bethan Psaila,Supat Thongjuea	34
5	VALERIE: Visual-based inspection of alternative splicing events at single-cell resolution 2020 ·PLoS Computational Biology ·Wei Wen,Adam J. Mead,Supat Thongjuea	9
6	Correction: miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC 2020 ·Cell Death and Disease ·(unknown),(unknown),Fengming Yang,(unknown),Chunfeng Pan,Xianglong Pan,(unknown),Jun Wang,Wei Wen,Zhicheng He,Jing Xu,Xinfeng Xu,Quan Zhu,Liang Chen	5
7	Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer 2019 ·PLoS ONE ·Wei Wen,Chee‐Onn Leong	77
8	Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer 2019 ·Translational Oncology ·Wei Wen,Ernest Han,Thanh H. Dellinger,Jun Wu,(unknown),Ralf Buettner,David Horne,Richard Jove,John H. Yim	9
9	Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer 2018 ·Cancer Research ·Jingmei Li,(unknown),Wei Wen,Brennan Decker,Mikael Eriksson,(unknown),(unknown),Alison M. Dunning,Jamie Allen,Craig Luccarini,Karen A. Pooley,Jacques Simard,Leila Dorling,Douglas F. Easton,Soo‐Hwang Teo,Per Hall,Kamila Czene	16
10	Learning Intrinsic Sparse Structures within Long Short-Term Memory 2017 ·International Conference on Learning Representations ·Wei Wen,Yuxiong He,Samyam Rajbhandari,Minjia Zhang,Wenhan Wang,Fang Liu,Bin Hu,Yiran Chen,Hai Li	14
11	Faster CNNs with Direct Sparse Convolutions and Guided Pruning 2016 ·International Conference on Learning Representations ·Jongsoo Park,(unknown),Wei Wen,Ping Tang,Hai Li,Yiran Chen,Pradeep Dubey	18
12	Holistic SparseCNN: Forging the Trident of Accuracy, Speed, and Size 2016 ·arXiv (Cornell University) ·Jongsoo Park,(unknown),Wei Wen,Hai Li,Yiran Chen,Pradeep Dubey	11
13	Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Cai M. Roberts,Sophia Allaf Shahin,Wei Wen,James Finlay,Juyao Dong,Ruining Wang,Thanh H. Dellinger,Jeffrey I. Zink,Fuyuhiko Tamanoi,Carlotta A. Glackin	67
14	Therapeutic potential of ruxolitinib in human ovarian cancer 2016 ·Gynecologic Oncology ·(unknown),Thanh H. Dellinger,Wei Wen,Jing Wu,Richard Jove,(unknown),(unknown)	1
15	Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients 2015 ·Gynecologic Oncology ·Hanis Nazihah Hasmad,(unknown),Wei Wen,Daniel J. Park,Tú Nguyen‐Dumont,Peter Choon Eng Kang,Eswary Thirthagiri,(unknown),Boon Kiong Lim,Melissa C. Southey,Yin Ling Woo,Soo‐Hwang Teo	16
16	MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells 2013 ·Cancer Biology & Therapy ·Lucy Liu,(unknown),(unknown),Yan Tian,Jun Wu,Wei Wen,Léandros Skaltsounis,Richard Jove	26
17	Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively‐activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells 2012 ·Molecular Oncology ·Sangkil Nam,Wei Wen,Anne Schroeder,Andreas Herrmann,Hua Yu,Xinlai Cheng,Karl‐Heinz Merz,Gerhard Eisenbrand,Hongzhi Li,Yate‐Ching Yuan,Richard Jove	69
18	Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment 2010 ·Clinical Cancer Research ·Wei Liang,Maciej Kujawski,Jun Wu,Jianming Lu,Andreas Herrmann,Sofia Loera,Yun Yen,Frank Lee,Hua Yu,Wei Wen,Richard Jove	51
19	Baicalin increases VEGF expression and angiogenesis by activating the ERR /PGC-1 pathway 2010 ·Cardiovascular Research ·Kuo Zhang,Lü Jin,Taizo Mori,(unknown),Timothy W. Synold,Sheng Chen,Wei Wen	90
20	The Src family kinase inhibitor, dasatinib, inhibits angiogenesis in vitro and in vivo 2008 ·Cancer Research ·Wei Liang,Andreas Herrmann,Michael Hedvat,Jianming Lu,(unknown),Wei Wen,Frank Lee,Richard Jove	3

About Wei Wen

Wei Wen is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 76 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cancer Mechanisms and Therapy (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Cancer Research (469 citations), Oncology (551 citations) and Molecular Biology (991 citations). Wei Wen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Thanh H. Dellinger, Marsha A. Moses, Dmitri Wiederschain, Jack L. Arbiser, Ernest Han, Chee‐Onn Leong, John H. Yim, Richard Jove, Yiran Chen and Carlotta A. Glackin. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact